Cernostics Announces New Scientific Advisors
Tuesday, April 16, 2013 - 15:31
in Health & Medicine
John M. Inadomi, M.D., of the University of Washington, and Robert F. Murphy, Ph.D., of Carnegie Mellon University, will serve as scientific advisors to Cernostics. They will assist Cernostics, a life science firm that develops and commercializes advanced cancer diagnostic tests, to oversee efforts to develop a test that predicts the risk of esophageal cancer in patients with severe gastro-esophageal reflux disease (GERD) and Barrett's Esophagus.